Oragenics Share Price

Oragenics Share Price

AMEX: OGEN | Micro Cap | Healthcare
$0.20
+$0.20 (--%) Last updated on 18 Nov, 2026 | 23:14 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Oragenics Stock Performance

Open
$0.20
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.20 - $0.20
Year Range
$0.17 - $1.08
Volume
3,642
Average Traded
$0.20

Oragenics Share Price Chart

Line chart of the Oragenics price trend over the selected period. The price rose overall, ranging from 0.20 to 0.20, ending at 0.20.
$0.20$0.20
L
Show Current Price
H

Oragenics Stock Fundamentals & Key Indicators

Market Cap
$429473.83
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.23
Revenue (TTM)
$0.00
Return On Equity (TTM)
-274.70%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
17.59%

Oragenics Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.07-$2.29-$2.20-$2.53
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A25.41%3.93%-15.00%

Oragenics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.13$0.04$0.00$0.00
Net Profit-$14.29-$20.66-$10.57-$9.84
Net Profit Margin-10992.31%-51650.00%N/AN/A
Income ChangeN/A-44.58%48.84%6.91%

Oragenics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.01.10.47
Current Assets10.071.473.8714.29
Total Assets10.071.474.9714.76
Non Current Liabilities0.00.00.00.15
Current Liabilities1.791.681.81.6
Total Liabilities1.791.681.81.75
Shareholders' Equity8.28-0.213.1713.01

Oragenics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-9.25-8.6-7.29-15.23
Investing0.00.0-0.94-0.12
Financing16.785.980.28-0.49

Corporate Actions

Split
Ex-date: 03 Jun 2025

Split
Ex-date: 23 Jan 2023

About Oragenics

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Oragenics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.37
$0.20
-45.55%
Oct 2026
$0.49
$0.37
-24.90%
Sep 2026
$0.52
$0.49
-7.49%
Aug 2026
$0.52
$0.53
+6.80%
Jul 2026
$0.60
$0.50
-13.79%
Jun 2026
$0.61
$0.58
-4.45%
May 2026
$0.63
$0.61
+6.49%
Apr 2026
$0.57
$0.57
+1.79%
Mar 2026
$0.81
$0.56
-33.01%
Feb 2026
$0.81
$0.84
+3.47%
Jan 2026
$0.82
$0.81
+7.59%
Dec 2025
$0.85
$0.75
-14.66%

Oragenics Share Price FAQs